SART3 (NM_014706) Human Mass Spec Standard

CAT#: PH310837

SART3 MS Standard C13 and N15-labeled recombinant protein (NP_055521)



  View other "SART3" proteins (3)

Need it in bulk or customized?
Get a free quote

CN¥ 19,520.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (2)
Transient overexpression lysate of squamous cell carcinoma antigen recognized by T cells 3 (SART3)
    • 100 ug

CN¥ 3,080.00


SART3 Rabbit polyclonal Antibody
    • 100 ul

CN¥ 1,999.00
CN¥ 3,280.00

Specifications

Product Data
Description SART3 MS Standard C13 and N15-labeled recombinant protein (NP_055521)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC210837
Predicted MW 109.9 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_055521
RefSeq Size 4377
RefSeq ORF 2889
Synonyms DSAP1; P100; p110; p110(nrb); RP11-13G14; TIP110
Locus ID 9733
Cytogenetics 12q23.3
Summary The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...